Journal article

Varied presentation of post Covid mucormycosis in a tertiary care centre in Northern India

NANeda Ahsan NANeda Ahsan MFMazhar Fahim MFMazhar Fahim FLFatma Lubna FLFatma Lubna ZHZohra Nahid Hashmi ZHZohra Nahid Hashmi SASaquib Anwer SASaquib Anwer KAKafil Akhtar KAKafil Akhtar
Year2022
Volume7
Issue1
Pages16-19

Abstract

Aims and Objectives: To study the cytomorphological presentation of post covid mucormycosis.
Materials and Methods: A retrospective observational study was conducted at a tertiary care center in Northern India for a period of six months, in patients with post covid mucormycosis.
Results: The study included 50 cases with post covid mucormycosis. Males with 28 cases (56.0%) were more commonly affected than females. Nose comprising of 36 cases (72.0%) was the most commonly affected area, with nasal cavity showing 24 cases (48.0%) being most common site within the nose. 36 cases (72.0%) were positive exclusively for Mucormycosis. 10.0% cases of mucor showed superadded bacterial infection. Candida was seen in 03 cases (6.0%) and aspergillosis in 02 cases (4.0%). There were 6.0% cases of mucormycosis with associated chronic osteomyelitis. All the patients had a history of steroid use throughout their coronavirus treatment.
Conclusions: A rare but fatal fungal infection (mucormycosis) has a strong association with covid-19 infection, in active as well as recovered patients, particularly in those with co-morbid medical conditions and treated with high doses of corticosteroids.
 

Keywords: Covid­19, Mucormycosis, Post covid treatment, SARS­CoV­2 Infection

Cite this article

Citation data